---
title: "Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300760.SZ.md"
symbol: "300760.SZ"
name: "Shenzhen Mindray Bio-Medical Electronics Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-19T22:47:16.037Z"
locales:
  - [en](https://longbridge.com/en/quote/300760.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300760.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300760.SZ.md)
---

# Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)

## Company Overview

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, accessories, infusion system, orthopedics, IT Products, cardiovascular intervention, animal medical, and OEM products. It also provides various solutions, such as M-connect IT, M-connect ER, M-connect ICU, M-connect OR, and M-connect CCU solutions; advanced patient monitoring and intelligent ventilation, emergency ultrasound solutions, and fast defibrillation; customized pendant and critical care ultrasound solutions; precise anesthesia, minimally invasive surgery, infusion system, surgical lights, and anesthesia ultrasound solutions; laboratory diagnostics, medical imaging, and cybersecurity solutions.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.mindray.com](https://www.mindray.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.41)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 32 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.16% |  |
| Net Profit YoY | -29.63% |  |
| P/B Ratio | 4.73 |  |
| Dividend Ratio | 2.96% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 189359967919.11 |  |
| Revenue | 33365105071.81 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.92% | A |
| Profit Margin | 23.47% | A |
| Gross Margin | 61.87% | A |
| Revenue YoY | -6.16% | D |
| Net Profit YoY | -29.63% | D |
| Total Assets YoY | 2.14% | C |
| Net Assets YoY | 2.96% | C |
| Cash Flow Margin | 128.01% | B |
| OCF YoY | -6.16% | D |
| Turnover | 0.57 | C |
| Gearing Ratio | 24.77% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shenzhen Mindray Bio-Medical Electronics Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-6.16%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-29.63%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.73",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.96%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "189359967919.11",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "33365105071.81",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.92%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "23.47%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "61.87%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-6.16%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-29.63%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.14%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.96%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "128.01%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-6.16%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.57",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "24.77%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.47 | 8/64 | 29.31 | 26.37 | 24.66 |
| PB | 4.78 | 53/64 | 7.30 | 6.38 | 5.56 |
| PS (TTM) | 5.74 | 27/64 | 8.08 | 7.48 | 6.61 |
| Dividend Yield | 2.93% | 8/64 | 3.26% | 2.60% | 2.29% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T16:00:00.000Z

Total Analysts: **26**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 21 | 81% |
| Overweight | 4 | 15% |
| Hold | 1 | 4% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 158.15 |
| Highest Target | 313.62 |
| Lowest Target | 195.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300760.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300760.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300760.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300760.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**